Abstract
Lung injury resulting from inhaled toxins continues to be associated with significant morbidity and mortality. Inhalation injury, when combined with epidermal burns, increases fluid resuscitation requirements. While cutaneous burns can be excised and grafted, pulmonary mucosa must be protected from secondary injury caused by mechanical ventilation, resuscitation, and infections to allow for host repair mechanisms. Many of the consequences of smoke inhalation result from activation of an inflammatory response with immune mediators which are not completely understood. Morbidity from smoke inhalation results from thermal injury and inhaled toxins.
Keywords: Burn, inhalation, airway, ARDS, bronchoscopy.
Current Respiratory Medicine Reviews
Title:Inhalational Injury: A Brief Review of Pathophysiology, Diagnosis and Treatment
Volume: 11 Issue: 1
Author(s): Delphine Engel and Riyad Karmy-Jones
Affiliation:
Keywords: Burn, inhalation, airway, ARDS, bronchoscopy.
Abstract: Lung injury resulting from inhaled toxins continues to be associated with significant morbidity and mortality. Inhalation injury, when combined with epidermal burns, increases fluid resuscitation requirements. While cutaneous burns can be excised and grafted, pulmonary mucosa must be protected from secondary injury caused by mechanical ventilation, resuscitation, and infections to allow for host repair mechanisms. Many of the consequences of smoke inhalation result from activation of an inflammatory response with immune mediators which are not completely understood. Morbidity from smoke inhalation results from thermal injury and inhaled toxins.
Export Options
About this article
Cite this article as:
Engel Delphine and Karmy-Jones Riyad, Inhalational Injury: A Brief Review of Pathophysiology, Diagnosis and Treatment, Current Respiratory Medicine Reviews 2015; 11 (1) . https://dx.doi.org/10.2174/1573398X1101150706144638
DOI https://dx.doi.org/10.2174/1573398X1101150706144638 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Many Roles of Chemokine Receptors in Neurodegenerative Disorders: Emerging New Therapeutical Strategies
Current Medicinal Chemistry Anti-Inflammatory Drugs in Psychiatry
Inflammation & Allergy - Drug Targets (Discontinued) Protein Kinase C Isozymes: Memory Therapeutic Potential
Current Drug Targets - CNS & Neurological Disorders Copper Status Abnormalities and How to Measure Them in Neurodegenerative Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Nuclear Medicine: Proof of Principle for Targeted Drugs in Diagnosis and Therapy
Current Pharmaceutical Design Role of Environmental Contaminants in the Etiology of Alzheimer’s Disease: A Review
Current Alzheimer Research Diabetes Mellitus and Vascular Endothelial Dysfunction: Current Perspectives
Current Vascular Pharmacology Possible Pathomechanisms Responsible for Injury to the Central Nervous System in the Settings of Chronic Cerebrospinal Venous Insufficiency
Reviews on Recent Clinical Trials Poly(ADP-Ribose)Polymerase 1 (PARP-1) Activation and Ca<sup>2+</sup> Permeable α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid (AMPA) Channels in Post-Ischemic Brain Damage: New Therapeutic Opportunities?
CNS & Neurological Disorders - Drug Targets Cerebral Arachidonate Cascade in Dementia: Alzheimers Disease and Vascular Dementia
Current Neuropharmacology Circular RNAs in Eukaryotic Cells
Current Genomics Drugs as Possible Triggers of Takotsubo Cardiomyopathy: A Comprehensive Literature Search - Update 2015
Current Clinical Pharmacology Elucidating Treatment of Alzheimer's Disease via Different Receptors
Current Topics in Medicinal Chemistry The Prevalence and Progression of Arterial Calcification in Patients with End-Stage Renal Disease
Vascular Disease Prevention (Discontinued) Potential Role of Polyphenols in the Prevention of Cardiovascular Diseases: Molecular Bases
Current Medicinal Chemistry Understanding the Binding Mechanism of Antagonist (AZD3293) Against BACE-1: Molecular Insights into Alzheimer’s Drug Discovery
Letters in Drug Design & Discovery Editorial [Hot Topic: Innate Immune Responses in CNS Neurodegenerative Diseases (Guest Editors: Hans van Noort and Sandra Amor)]
CNS & Neurological Disorders - Drug Targets Cardiovascular and Systemic Risk in Nonalcoholic Fatty Liver Disease - Atherosclerosis as a Major Player in the Natural Course of NAFLD
Current Pharmaceutical Design Impact of the CD40-CD40L Dyad in Alzheimers Disease
CNS & Neurological Disorders - Drug Targets Trait vs. State Markers for Schizophrenia: Identification and Characterization Through Visual Processes
Current Psychiatry Reviews